Oxford Nanopore Secures $41M for Development of GridIon Platform
April 26, 2011
Oxford Nanopore Secures $41M for Development of GridIon Platform
The funding will allow the company to validate its technology, including "interacting with key users who represent the spectrum of the particular application area, whether it's protein analysis or sequencing, and then ultimately, through commercialization," said CEO Gordon Sanghera.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Oxford Nanopore's Silence Stirs Noise at AGBT; Technical Issues, Arbitration May Be Behind Reticence
February 26, 2013 / In Sequence - With Illumina Acquisition on Ice, What is Roche's Next Move in the Sequencing Space?
April 24, 2012 / In Sequence - Shares of Sequencing Instrument Makers Fall as Oxford Nanopore Unveils Platforms
February 17, 2012 / GenomeWeb Daily News - Oxford Nanopore to Commercialize DNA Strand Sequencing this Year; Illumina not Involved
February 7, 2012 / In Sequence - Oxford Nanopore Raises $28M from Multiple Investors; Embarks on Protein Analysis Application
February 2, 2010 / In Sequence